FENG Xue
Profession
E-MAIL： [email protected]
TEL：(86) 13701813929
RESEAR FIELD：Liver Transplantation
Biography
Dr. Feng Xue is a transplant physician and the Pediatric Director of Liver Transplantation at Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine, with a primary focus in management of adult and pediatric liver transplantation and transplant immunity. Areas of clinical expertise include: Improving long-term outcomes for liver transplant recipients by immune monitoring and personalized immunosuppression. Management of post-LT complications, especially in pediatric liver transplant recipients.
In addition to her clinical activities, Dr. Xue is active in researches including molecular mechanisms of drug-induced liver injury (DILI), EBV associated PTLD, improving vaccine outcomes for post-LT recipients under immunosuppression. She has also been active in education, having been served as the surgery teaching director for the department. In addition to her work with medical students, Dr. Xue has mentored many transplant surgery fellows, both domestic and overseas, and she has been active in international collaboration.
Publications
Xu D, Qu X, Tian Y, Jie Z, Xi Z, Xue F, Ma X, Zhu J, Xia Q. Macrophage Notch1 Inhibits TAK1 Function and RIPK3-Mediated Hepatocyte Necroptosis Through Activation of β-Catenin Signaling in Liver Ischemia and Reperfusion Injury. Cell Commun Signal. 2022 Sep 16;20(1):144. doi: 10.1186/s12964-022-00901-8. IF: 7.525 Q2
Wu J, Xie F, Ji H, Zhang Y, Luo Y, Xia L, Lu T, He K, Sha M, Zheng Z, Yong J, Li X, Zhao D, Yang Y, Xia Q, Xue F. A Clinical-Radiomic Model for Predicting Indocyanine Green Retention Rate at 15 Min in Patients With Hepatocellular Carcinoma. Front Surg. 2022 Mar 24;9:857838. 國家科技部重大專項(xiàng)基金：No.2018ZX10723203-003-003
通訊作者 IF: 2.562 Q2
周艾煒，劉源，薛峰等。兒童肝移植免疫耐受的研究進(jìn)展,。《器官移植》述評
國家自然科學(xué)基金（No.82000586; No.82170669） 核心期刊 通訊作者
Zhu Y, Zhang Z, Song J, Qian W, Gu X, Yang C, Shen N, Xue F, and Tang Y. SARS-CoV-2-encoded microRNAs inhibit host type I interferon pathway and mediate allelic differential expression of susceptible gene. Frontiers in immunology 2021 December 23;12: 767726. 共同通訊作者 IF 8.786,，Q1
Zheng JX, Zhou H, Yang TH, Liu JC, Qin T, Gu XQ, Wu J, Zhang Y, Wang HL, Tang YJ, Xue F, Mao YM and Xia Q. Protective role of microRNA-31 in acetaminophen-induced hepatic necrotic cell death: a negative regulator of c-Jun N-terminal kinase (JNK) signaling pathway. Cell Mol Gastroenterol Hepatol 2021 Jul 23;S2352-345X(21)00156-9. 國自然基金No.81670602和81470847,；國家科技部重大專項(xiàng)基金：No.2018ZX10723203-003-003
通訊作者,， IF 8.797, Q1
Liu JC, Fei Y, Zhou T, Ji H, Wu J, Gu XQ, Luo Y, Zhu JJ, Feng MX, Wan P, Qiu BJ, Lu YF, Yang T, Deng PF, Zhou CP, Gong DC, Deng J, Xue F, Xia Q. Bile acids impair vaccine response in children with biliary atresia. Frontiers in immunology 2021 April;12:642546 仁濟(jì)臨床科研創(chuàng)新培育基金 通訊作者,， IF 8.786, Q1
Gu XQ, Tang D, Tang YJ, Wan P, Qin T, Yang TH, Wu J, Ji H, Liu JC, Xue F, Xia Q. Multiple microRNAs regulate tacrolimus metabolism through CYP3A5. Pharmacol Res. 2021 Feb; 164:105382. doi: 10.1016/j.phrs.2020.105382. Epub 2020 Dec 18.
國自然基金No.81670602 通訊作者,，IF 10.334, Q1
Xue, F, Gao W, Qin T, et al. Immune Cell Function Assays in the Diagnosis of Infection in Pediatric Liver Transplantation: An open-labeled, two center prospective cohort study. Transl Pediatr 2021;10(2): 333-343. 國自然基金No.81670602，申康三年,，IF 2.488
Tang J, Wang D, Shen Y, and Xue F. ATG16L2 overexpression is associated with a good prognosis in colorectal cancer. J Gastrointest Oncol 2021 https://dx.doi.org/10.21037/jgo-21-495. 通訊作者,， IF 2.892
Deng J, Chen Q, Chen Z, Liang K, Gao X, Wang X, Makota FV, Ong HS, Wan Y, Luo K, Gong D, Yu X, Camuglia S, Zeng Q, Zhou T, Xue F, He J, Wei Y, Xiao F, Ma J, Hill DL, Pierson W, Nguyen THO, Zhou H, Wang Y, Shen W, Sun L, Li Z, Xia Q, Qian K, Ye L, Rockman S, Linterman MA, Kedzierska K, Shen N, Lu L, Yu D. The metabolic hormone leptin promotes the function of TFH cells and supports vaccine responses. Nat Commun. 2021 May 24;12(1):3073. doi: 10.1038/s41467-021-23220-x. PMID: 34031386; PMCID: PMC8144586.
Wang T, Feng M, Luo C, Wan X, Pan C, Tang J, Xue F, Yin M, Lu D, Xia Q, Li B, Chen J. Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Cell Transplant. 2021 Jan-Dec;30:963689721996649. doi: 10.1177/0963689721996649. PMID: 33631963; PMCID: PMC7917414.
賈麗燕，景懿磊,，張千，呂曉穎,，吳新瑞,，馬方暉,，劉雯瓊，薛峰*,，朱燕波*. 新型冠狀病毒肺炎爆發(fā)期間肝移植受者服藥依從性與生命質(zhì)量調(diào)查研究[J].肝臟.2021;26(6): 655-660. 國家科技部重大專項(xiàng)基金：No.2018ZX10723203-003-003 共同通訊作者
吳新瑞,，朱燕波*，薛峰*,，景懿磊,，馬方暉，劉雯瓊. 成年肝移植受者生命質(zhì)量與自我領(lǐng)導(dǎo)力現(xiàn)狀及關(guān)系探究. （《醫(yī)學(xué)與社會》投稿中） 國家科技部重大專項(xiàng)基金：No.2018ZX10723203-003-003 共同通訊作者
張家旭,封明軒,邱必軍,等. 兒童肝移植受者疫苗接種的研究進(jìn)展[J]. 中華器官移植雜志,2021,42(5):312-316. DOI:10.3760/ cma.j.cn421203-20201106-00379.
陳弘揚(yáng),高敬陽,趙地,吳忌,陳金軍,全顯躍,李欣明,薛峰,周沐瑤,柏冰冰.LFSCA-UNet:基于空間與通道注意力機(jī)制的肝纖維化區(qū)域分割網(wǎng)絡(luò)[J].中國圖象圖形學(xué)報(bào),2021,26(09):2121-2134. 國家科技部重大專項(xiàng)基金：No.2018ZX10723203-003-003
Liu Y, Luo Y, Xia L, Qiu BJ, Zhou T, Feng MX, Xue F, Chen XS, Han LS, Zhang JJ, Xia Q.
Living-donor liver transplantation for children with tyrosinemia type I. J Dig Dis. 2020 Mar;21(3):189-194.
Qin T, Gu X, Jeong S, Song Y, Liu J, Zheng J, Xue F*, Xia Q. Impact of EBV infection and immune function assay for lymphoproliferative disorder in pediatric patients after liver transplantation: a single center experience. Hepatobiliary & Pancreatic Diseases International 2020;19: 3-11. 國自然基金No.81670602,。 通訊作者,，IF 2.428
Liu Y, Luo Y, Xia L, Qiu B, Zhou T, Feng M, Xue F, Chen X, Han L, Zhang J, Xia Q. The Effects of Liver Transplantation in Children With Niemann-Pick Disease Type B. Liver Transpl. 2019 Aug;25(8):1233-1240.
Zheng JX, Tang YJ, Yang TH, Qin T, Liu JC, Gu XQ, Xue F, and Xia Q. The long non-coding RNAs exert regulatory roles in acetaminophen induced liver injury. Journal of Digestive Diseases 2019;20: 308-317. 國自然基金No.81670602和81470847 通訊作者 IF: 1.82
秦天* 顧向前 鄭建新劉金川 唐元家 薛峰# 夏強(qiáng)#。兒童活體肝移植術(shù)后藥物代謝差異相關(guān)miRNA及IncRNA的高通量測序分析,。國自然基金No.8167060,，中華器官移植雜志，2019,40. 通訊作者
萬平,陸曄峰,邱必軍,等. 親屬活體肝移植治療兒童甲基丙二酸血癥30例的臨床分析[J]. 中華器官移植雜志,2019,40(11):683-686. DOI:10.3760/cma.j.issn.0254-1785.2019.11.008.
萬平,邱必軍,封明軒,等. 兒童肝移植術(shù)后微小病毒B19感染相關(guān)性貧血二例[J]. 中華器官移植雜志,2019,40(7):410-413. DOI:10.3760/cma.j.issn.0254-1785.2019.07.007.
Xue F, Shi SJ, Zhang ZZ, et al. Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation. Oncol Lett. 2018 Apr;15(4):5481-5488. doi: 10.3892/ol.2018.8019. Epub 2018 Feb 9. PMID: 29552189; PMCID: PMC5840532.Oncol Lett 2018 Apr;15(4):5481-5488. IF 2.311
Zhou T, Zhang JJ, Luo Y, Liu Y, Zhuang SY, Xue F, Han LZ, Xia Q. Clinical characteristics and outcome of liver transplantation for Alagille syndrome in children. J Dig Dis. 2017 Nov;18(11):658-662.
劉源,夏強(qiáng),張建軍,薛峰,夏雷,羅毅,邱必軍,封明軒,陳小松,韓龍志.親體肝移植治療新生兒肝內(nèi)膽汁淤積型希特林缺乏癥1例[J].實(shí)用器官移植電子雜志,2018,6(06):461-463.
施少軍,，鄭建新,，秦天等。改良大鼠離體肝臟灌注模型在供肝冷保存中的應(yīng)用研究,?！段改c病學(xué)》2017;22(9):517-22。 通訊作者,，核心期刊
孟稼祥,萬平,薛峰,羅毅,邱必軍,封明軒,周韜,張建軍,李敏,夏強(qiáng).兒童肝移植術(shù)后病原菌感染的危險(xiǎn)因素分析[J].肝膽外科雜志,2017,25(06):412-415.
Shi SJ and Xue F. Current Antioxidant Treatments In Organ Transplantation. Oxid Med and Cell Longev 2016;2016:8678510. doi: 10.1155/2016/8678510. Epub 2016 Jun 15. Review.
通訊作者 IF: 4.492
施少軍,，薛峰。消化系統(tǒng)腫瘤外周血循環(huán)腫瘤細(xì)胞的研究進(jìn)展,?！段改c病學(xué)》2016;21(2)107-110。 通訊作者
Zhu W, Kuziora M, Creasy T, Lai Z, Morehouse C, Guo X, Sebastian Y, Shen D, Huang J, Dry JR, Xue F, Jiang L, Yao Y, Higgs BW. BubbleTree: an intuitive visualization to elucidate tumoral aneuploidy and clonality using next generation sequencing data. Nucleic Acids Res. 2016 Feb 29;44(4):e38. doi: 10.1093/nar/gkv1102. Epub 2015 Nov 17. PMID: 26578606; PMCID: PMC4770205. IF: 9.112
Xue F, Higgs BW, Huang J, Morehouse C, Zhu W, Yao X, Brohawn P, Xiao Z, Sebastian Y, Liu Z, Xia Y, Shen D, Kuziora M, Dong Z, Han H, Gu Y, Gu J, Xia Q and Yao Y. HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. J Transl Med. 2015 Dec 11;13:379-93. IF:4.23
Nie H, Li J, Yang XM, Cao QZ, Feng MX, Xue F, Wei L, Qin W, Gu J, Xia Q, Zhang ZG. Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma. Hepatology. 2015 Oct;62(4):1145-59.
Yang TH, Chen YK, Xue F, Han LZ, Shen CH, Zhou T, Luo Y, Zhang JJ, and Xia Q. Influence of CYP3A5 genotypes in tacrolimus dose requirement: age and its pharmacological interaction with ABCB1 genetics in Chinese pediatric liver transplantation. Int J Clin Pract 2015;69(Suppl.183):53-62. 通訊作者 IF 2.54
Li H, Xia Q, Zeng B, Li ST, Liu H, Li Q, Li J, Yang SY, Dong XJ, Gao T, Munker S, Liu Y, Liebe R, Xue F, Li QG, Chen XS, Liu Q, Zeng H, Wang JY, Xie Q, Meng QH, Wang JF, Mertens PR, Lammert F, Singer MV, Dooley S, Ebert MP, Qiu DK, Wang TL, Weng HL.
Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation. J Hepatol. 2015 Jul;63(1):50-9.
Zhao D, Long XD, Lu TF, Wang T, Zhang WW, Liu YX, Cui XL, Dai HJ, Xue F, Xia Q. Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma. Int J Cancer. 2015 Jun 1;136(11):2556-65.
陳奕寬,，薛峰,，沈叢歡等。嬰幼兒肝移植供受體的CYP3A5基因多態(tài)性對他克莫司藥動學(xué)的影響,?！吨腥A器官移植雜志》2015;36(1):1-6。 通訊作者
劉煥榮,，陸蕓,，張正國，王建,，劉光偉,，薛峰。地塞米松調(diào)節(jié)T細(xì)胞免疫應(yīng)答保護(hù)小鼠急性炎性肝損傷的作用,?！段改c病學(xué)》2015;20(6)324-8,。 通訊作者
Zhao Y, Xue F, Sun J, Guo S, Zhang H, Qiu B, Gu J, Wang W, Zhang Z, Tang N, Zhou X, Yu J and Xia Q. Genome-wide methylation profiling of different stages of HBV-related HCC development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of HCC. Clin Epigenetics 2014;6:1-18. 共同第一 IF 6.22
Xue F, Han LZ, Chen YK, et al. CYP3A5 genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients. Pediatr Transplant. 2014Mar;18(2):166-76. IF 1.63
Fu Y, Feng MX, Yu J, Ma MZ, Liu XJ, Li J, Yang XM, Wang YH, Zhang YL, Ao JP, Xue F, Qin W, Gu J, Xia Q, Zhang ZG. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling. Oncotarget 2014;5(16):6701-15. IF 6.627
Chen Y, Han L, Xue F, Shen C, Lu J, Yang T, Zhang J, and Xia Q. Personalized tacrolimus dose requirement by CYP3A5 but not ABCB1 or ACE genotyping in both recipient and donor after pediatric liver transplantation. PLoS One 2014; 9(10): e109464. doi: 10.1371/journal.pone.0109464. eCollection 2014 通訊作者 IF 3.534
Feng MX, Ma MZ, Fu Y, Li J, Wang T, Xue F, Zhang JJ, Qin WX, Gu JR, Zhang ZG, Xia Q. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation. Mol Cancer. 2014;13(1):226. IF 5.397
Li J, Yang XM, Wang YH, Feng MX, Liu XJ, Zhang YL, Huang S, Wu Z, Xue F, Qin WX, Gu JR, Xia Q, Zhang ZG. Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling. J Hepatol 2014;60(6):1225-34. IF 10.40
Liu H, Yang H, Chen X, Lu Y, Zhang Z, Wang J, Zhang M, Xue L, Xue F, Liu G. Cellular metabolism modulation in T lymphocyte immunity. Immunology. 2014 May 19. doi: 10.1111/imm.12321. 共同通訊作者 IF 4.078
Li J, Yang XM, Wang YH, Feng MX, Liu XJ, Zhang YL, Huang S, Wu Z, Xue F, Qin WX, Gu JR, Xia Q, Zhang ZG. Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling. J Hepatol. 2014 Jun;60(6):1225-34.
盧軍，王樹軍,，季萍,，王穎，韓龍志,，夏韻,，薛峰。41例嬰幼兒活體肝移植術(shù)后T細(xì)胞分布特征及其在術(shù)后感染監(jiān)測中的意義,?！冬F(xiàn)代免疫學(xué)》2014;34(3):203-209. 通訊作者
楊太華，薛峰,。釔９０動脈栓塞內(nèi)放療治療肝細(xì)胞癌：生物學(xué)經(jīng)驗(yàn),、當(dāng)前挑戰(zhàn)與臨床展望?！陡闻K》2014;19(12):968-74,。（綜述） 通訊作者，核心期刊
Long XD, Zhao D, Wang C, Huang XY, Yao JG, Ma Y, Wei ZH, Liu M, Zeng LX, Mo XQ, Zhang JJ, Xue F, Zhai B, Xia Q. Genetic Polymorphisms in DNA Repair Genes XRCC4 and XRCC5 and Aflatoxin B1-related Hepatocellular Carcinoma. Epidemiology 2013;24(5):671-81. IF 5.738
Long XD, Yao JG, Zeng Z, Ma Y, Huang XY, Wei ZH, Liu M, Zhang JJ, Xue F, Zhai B, Xia Q. Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma. Hepatology 2013;58(1):171-81. IF 12.003
Xue F, Li H, Zhang J, Lu J, Xia Y, and Xia Q. miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Genes Immun 2013;14(2): 127-31. IF 3.685
Kawai K, Xue F, Takahara T, Kudo H, Yata Y, Zhang W, and Sugiyama T. Matrix metalloproteinase-9 contributes to the mobilization of bone marrow cells in the injured liver. Cell Transplant 2012;21: 453-64. 共同第一 IF 4.422
Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q, Zhang J. Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun 2012;425(2):468-72. IF 2.406
Xu N, Zhang J, Shen C, Luo Y, Xia L, Xue F, Xia Q. Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. Biochem Biophys Res Commun 2012; 423(4):826-31. IF 2.406
Zhu JJ, Xia Q, Zhang JJ, Xue F, Chen XS, Li QG, Xu N. Living donor liver transplantation in 43 children with biliary atresia: a single-center experience from the mainland of China. Hepatobiliary Pancreat Dis Int 2012;11(3):250-5.
Zhou T, Xue F, Han LZ, Xi ZF, Li QG, Xu N, Zhang JJ, and Xia Q. Invasive Fungal Infection after Liver Transplantation: Risk Factors and Significance of Immune Cell Function Monitoring. J Dig Dis 2011; 12:467-475. 通訊作者 IF 1.853
薛峰 邱德凱,。肝移植的內(nèi)科指征及臨床進(jìn)展,。《胃腸病學(xué)》2011;16(12):705-711,。
鄧維 劉蕾 薛峰 韓龍志 奚志峰 張建軍 夏強(qiáng),。肝移植早期他克莫司的藥動學(xué)特征及干擾因素分析?！吨腥A器官移植雜志》2011,，32(12)：730-734。 通訊作者
夏強(qiáng),，邱必軍,，薛峰。影響肝移植物長期存活的因素,?！陡闻K移植臨床病理學(xué)》（軍事醫(yī)學(xué)科學(xué)出版社）2011，162-170,。
Xue F, Zhang JJ, Xu LM, Zhang C, Xia Q. Protective Effects of HGF-MSP Chimer in a Rat Model of Liver Ischemia-reperfusion Injury. J Dig Dis 2010, 11:299-305. IF 1.853
薛峰 徐龍妹 張程 鄧維 夏韻 張建軍 夏強(qiáng),。重組人肝細(xì)胞生長因子激活因子(HGFA)質(zhì)粒構(gòu)建、表達(dá)及其功能研究,?！段改c病學(xué)》2010，15（1）：8-11。 通訊作者
Xue F, Zhang JJ, Han LZ, Li QG, Xu N, Zhou T, Xi ZF, Wu YM and Xia Q. Immune Cell Functional Assay in Monitoring of Liver Transplantation Recipients with Infection. Transplantation 2010;89(8):620-26. IF 3.789
Yata Y, Xue F, Takahara T, Kudo H, Hirano K, Yasumura S, Minemura M, Scanga AE, Sugiyama T. Docetaxel inhibits progression of human hepatoma cell line in vitro and is effective in advanced hepatocellular carcinoma. Hepatol Res.2010 Mar 1;40(3):304-10. IF 1.857
薛峰 張建軍 李齊根 張明 宋玉 徐寧 周韜 鄧維 王思岳 夏強(qiáng),。他克莫司緩釋膠囊對肝移植術(shù)后穩(wěn)定期患者的臨床療效分析,?！吨腥A移植雜志》 2009,，3：19-23。
張建軍 薛峰 陳小松 韓龍志 周韜 王鑫 奚志峰 夏強(qiáng),。ImmuKnowTM細(xì)胞免疫功能測定在監(jiān)控肝移植術(shù)后感染中的應(yīng)用,。《中華器官移植雜志》 2009,，30：284-286,。
Xue F, Takahara T, Yata Y, Xia Q, Nonome K, Shinno E, Kanayama M, Takahara S, and Sugiyama T. Blockade of Rho/ROCK Signaling Can Prevent Progression of Hepatocellular Carcinoma in Matrix Metalloproteinase-dependent Manner. Hepatol Res.2008 38:810-17. IF 1.644
Tahahara T, Xue F, Mazzone M, Yata Y, Nonome K, Kanayama M, Kawai K, Pisacane AM, Takahara S, Li XK and Michieli P. Metron factor-1 prevent liver injury without promoting tumor growth and metastasis. Hepatology 2008;47(6):2010-25. IF11.355
Xue F, Zhang JJ, Qiu F, Zhang M, Chen XS, Li QG, HAN LZ, Xi ZF and Xia Q. A Rho signaling inhibitor, Y-27632, inhibits invasiveness of metastastic hepatocellular carcinoma in a mouse model. Chin Med J (Engl) 2007;120:2304-7. IF 0.571
Xue F, Isaka Y, Takahara T, Imamura R, Suzuki C, Ichimaru N, Michieli P, Takahara S. HGF-MSP chimera protects the kidneys from ischemia-reperfusion injury. Biochem Biophys Res Commun 2007;363:451-6. IF 2.849
Kanayama M, Takahara T, Yata Y, Xue F, Shinno E, Nonome K, Kudo H, Kawai K, Kudo T, Tabuchi Y, Watanabe A, Sugiyama T. Hepatocyte Growth Factor Promotes Colonic Epithelial Regeneration via Akt Signaling. Am J Physiol Gastrointest Liver Physiol. 2007 293(1):G230-9. IF 3.761
呂良敬，陳順樂,，顧越英,，沈南，鮑春德,，王元,，薛峰，葉萍,，俞忡照,。Rho60/SSA基因轉(zhuǎn)染Hep-2細(xì)胞作為間接免疫熒光檢測底物及其應(yīng)用?！稑?biāo)記免疫分析與臨床》 2006,，1：31-34.
Nonome K, Li XK, Takahara T, Kitazawa Y, Funeshima N, Xue F, Kanayama M, Shinno E, Kuwae C, Saito S, Watanabe A, and Sugiyama T. Human umbilical cord blood-derived cells differentiate into hepatocyte-like cells in the Fas-mediated liver injury model. Am J Physiol 2005；289(6): G1091-9. IF 3.472
Minemura M, Shimizu Y, Hirano K, Nakayama Y, Tokimitsu Y, Xue F, Takahara T, Watanabe A and Sugiyama T. Functional analysis of transactivation by mutants of hepatitis B virus X gene in human Hepatocellular carcinoma. Oncol Rep 2005; 14(2):495-499. IF 1.572
Takahara T, Nonome K, Xue F, Yata Y, Kanayama M, Li XK. Human umbilical cord blood cells differentiate into hepatocyte-like cells in Fas mediated liver injury of immune deficient mice. Hepatology 2004; 40(4):616A-616A Suppl.
Takahara T, Sugiyama K, Zhang LP, Ando O, Fujii M, Yaka Y, Xue F, Minemura M, Watanabe A. Cotreatment with interferon-??and –???reduces liver fibrosis in a rat model. Hepatol Res. 2004; 28(3):146-54. IF 1.173
Xue F, Takahara T, Yata Y, Kuwabara Y, Shinno E, Nonome K, Minemura M, Takahara S, Li X, Yamoto E, Watanabe A. Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 2003; 52(5): 694-700. IF 6.323
Xue F, Takahara T, Nonome K, Yata Y, Shinno E, Watanabe A. Rho-kinase inhibitor suppresses tumor growth and intrahepatic metastases of hepatocellular carcinoma - In vitro and in vivo study. Hepatology 2003; 38(4):400A-400A Suppl.
Lu LJ, Chen SL, Gu YY, Shen N, Bao CD, Wang Y, Xue F, Ye P, Yu CZ. Transfection, overexpression and clinical application of human 60 kDa Ro/SSA autoantigens in Hep-2 cells. Chinese Medical Journal 2003,；116:350-353. IF 0.571
Takahara T, Zhang LP, Xue F, Minemura M, Sato H, Watanabe A. Modulation of matrix metalloproteinase-9 in hepatic stellate cells by three-dimensional type I collagen: its activation and signaling pathway. Hepatol Res. 2003;26(4):318-26. IF 1.991
Xue F, Takahara T, Yata Y, Minemura M, Morioka CY, Takahara S, Yamato E, Dono K, Watanabe A. Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation. Gut 2002; 50(4): 558-62. IF 5.883
Xue F, Takahara T, Yata Y, Minemura M, Kuwabara Y, Watanabe A. HGF gene therapy by electroporation can enhance functional capacities of cirrhotic liver following 70% partial hepatectomy. Hepatology 2001; 34(4):382A-382A Part 2 Suppl.
Yang CD, Shen N, Xue F. Cloning and expression of beta 2-glycoprotein 1 recognized by antiphospholipid antibodies and its clinical investigation. Chin.Med J (Engl) 1999; 112(1): 67-71.
王元,，沈南，薛峰,，裴軍,，陳順樂?？沽字贵w陽性紅斑狼瘡患者外周血T細(xì)胞受體基因表達(dá)初探,。中國免疫學(xué)雜志 1999；10,。
Yang CD, Chen SL, Shen N, Qi M, Xue F. Detection of anti-recombinant beta 2-glycoprotein 1 and anti-recombinant beta 2-glycoprotein 1 fifth-domain antibodies in sera from patients with systemic lupus erythematosus. Rheumatol Int 1998; 18(1): 5-10.
薛峰,，沈南，陸瑜,，陳順樂. 重組自身抗原U1RNP多肽的制備及其在風(fēng)濕病診斷中的意義,。中華醫(yī)學(xué)雜志1997; 77(5): 340-43.
沈南，薛峰,，陸瑜,，陳順樂,。自身核抗原U1RNP70kD多肽全長基因克隆及鑒定。1997; 1: 15-18.
楊程德,，陳順樂,，沈南，陸瑜,，葉萍,，薛峰。人b2-GPI第五功能區(qū)cDNA的分子克隆及重組表達(dá),。上海免疫學(xué)雜志 1997,；4。
楊程德,，陳順樂,，沈南，裴軍,，薛峰,，陸瑜。人b2GPI全長cDNA的分子克隆及重組質(zhì)粒構(gòu)建,。上海免疫學(xué)雜志 1996,；6。
薛峰,，陳順樂. 自身核抗原U1RNP70KD的分子特性 中國免疫學(xué)雜志 1995; 11: 733-35..陸瑜,，沈南，薛峰,，陳順樂,。自身核抗原U1RNP70kD多肽分子中U1RNA結(jié)合功能區(qū)的cDNA分子克隆及其在大腸桿菌中的表達(dá)。上海免疫學(xué)雜志 1995; 15(4): 213-217.
